Pharma
How does rare disease prevalence impact drug pricing in England?
This article was originally published in PharmaPhorum. In this second article of a three-part series exploring pricing in Europe, CRA’s Life Sciences Practice team discusses the role that disease rarity plays in reimbursement decisions among payers in England, comparing assessment...
World Orphan Drug Congress Europe 2022
CRA is a proud sponsor of the congress. Cecile Matthews and Bhavesh Patel present their session titled “Project LEOPARD (Long-term Evolution & Outlook for Patient Access in Rare Disease): Initial findings on what the future holds.” Michele Pistollato presents h...
Part 2: Low-priced oncology disruptors - The cuckoo in the PD-1/PD-L1 nest or the runt of the clutch?
Part II of this article was originally published in PharmaPhorum.
Part 1: Low-priced oncology disruptors - The cuckoo in the PD-1/PD-L1 nest or the runt of the clutch?
Part I of this article was originally published in PharmaPhorum.
Seed investment to further advance our pioneering antiaging research
Five Alarm Bio writes...we are delighted to announce the close of our seed investment to further advance our pioneering antiaging research. The funding will enable our team to test new compounds for their ability to extend the healthy lifespan of cells and improve their function in dis...
ICRISAT and Eagle Genomics partnership to accelerate microbiome-based solutions to drive global climate resilience, sustainable food systems and improved nutrition
ICRISAT and Eagle Genomics sign Memorandum of Understanding
Community nursing team shares their first research experience
Area Nursing Manager Nicola Zolnhofer has published an article for the Royal College of Nursing highlighting her team’s experience of their first community research study. ...
Addenbrooke’s nurse flies to Turkey earthquake zone
An Addenbrooke’s emergency department nurse deployed to Turkey with the UK International Search and Rescue team (UKISAR) has told of their mission to save lives in the earthquake zone – and the terror of after-shocks. ...
Cambridge’s largest MedTech conference confirms final speaker list
The final list of speakers for Cambridge’s MedTech FUTURES conference has been confirmed. ...
Machine learning helps determine success of advanced genome editing
A new tool to predict the chances of successfully inserting a gene-edited sequence of DNA into the genome of a cell, using a technique known as prime editing, has been developed by researchers at the Wellcome Sanger Institute. ...